Disruptive Pharma Operations AB
559174-6085ActiveTransforming oral drugs via proprietary bioavailability enhancement technology.
Yleiskatsaus
- Tuntematon
- Työntekijät
- Tuntematon
- Liikevaihto
- 2018
- Perustettu
Avainpäättäjät
Stefan Ström
CFO
Peter Åsberg
CEO
Alexander Oker-Blom
Non-Executive Member of the Board
Marie Ehrling
Chairman
+17 lisää yhteystietoja Funnelfeedrissä
Kuvaus
Disruptive Pharma is an innovative, clinical-stage pharmaceutical development company based in Sweden. Their core mission is transforming drugs with poor oral bioavailability into effective, patient-friendly oral solid dosage forms. They achieve this using their proprietary technology platform calle...
Tunnisteet
Avainsanat
Teknologiat
Yritystiedot
- Toimiala
- Bioteknisk forskning och utveckling
- Oikeudellinen muoto
- Aktiebolag
- ALV-numero
- SE559174608501
Päättäjät
21 yhteystietoa FunnelfeedrissäStefan Ström
CFO
Peter Åsberg
CEO
Alexander Oker-Blom
Non-Executive Member of the Board
Marie Ehrling
Chairman
Johan Bygge
Chairman of the Board
Tobias Agervald
Non-Executive Member of the Board
Marc Willuhn
Process Development Director
Karin Botha
CFO
Sven Undeland
Commercial Director
David Bejker
Non-Executive Member of the Board
Gunilla Ekström
Non-Executive Member of the Board
Maria Strömme
Board Member and Founder
Martina Ferneman
Commercial Director (consultant)
Sofia Mogensen
R&D Director and Project Management (consultant)
Göran Forsberg
Non-Executive Member of the Board
Malin Vågerö
Director of R&D
Tobias Assander
Manufacturing and Process Development Lead
Muut yhteyshenkilöt
Andreas Fischer
Senior Product Development Scientist
Matilda Engman
Scientist
Hans Thor
Senior Analytical Chemist
Evelina Meurling
Senior Formulation Scientist
Samankaltaiset yritykset
20 samankaltaista yritystä FunnelfeedrissäVeltio Pharma AB
3 työntekijätProprietary platform enhances poorly soluble drug bioavailability using cellulose.
Ribocure Pharmaceuticals AB
20–49 työntekijätClinical stage biotech developing cutting-edge RNA therapeutics for rare diseases.
NANOFORM FINLAND OY
1–4 työntekijätNanoforming technology enhances drug performance across development stages.
Extem Pharma AB
2 työntekijätInnovative pharmaceutical startup specializing in 3D-printed, custom medications.
Double Bond Pharmaceutical AB
5–9 työntekijätDeveloping advanced drug delivery systems for targeted cancer and pneumonia treatment.
Selaa lisää
Kysymyksiä yrityksestä Disruptive Pharma Operations AB
Haluatko nähdä Funnelfeedrin toiminnassa?
Varaa ilmainen demo ja tutustu siihen, miten Funnelfeedr auttaa sinua löytämään ja konvertoimaan ihanteelliset asiakkaasi.
Varaa demo